GenSight Biologics Market Cap

GenSight Biologics has a market cap or net worth of $39.14 million as of April 24, 2025. Its market cap has increased by 17.35% in one year.

Market Cap

39.14M

Enterprise Value

58.04M

Revenue

2.72M

Ranking

n/a

PE Ratio

n/a

Stock Price

$0.24

Market Cap Chart

Since July 13, 2016, GenSight Biologics's market cap has decreased from 279.96M to 39.14M, a decrease of -86.02%. That is a compound annual growth rate of -20.07%.

Market Cap History

Date	Market Cap	% Change
Apr 23, 2025	33.79M	-1.26%
Dec 31, 2024	34.22M	20.63%
Dec 29, 2023	28.37M	-82.90%
Dec 30, 2022	165.86M	-42.89%
Dec 31, 2021	290.43M	-21.99%
Dec 31, 2020	372.30M	308.86%
Dec 31, 2019	Pro	Pro
Dec 31, 2018	Pro	Pro
Dec 29, 2017	Pro	Pro
Dec 30, 2016	Pro	Pro

Market Capitalization

Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.

Formula: Market Cap = Stock Price * Shares Outstanding

Full Definition

Related Stocks

Company	Market Cap
SS Innovations International	1.66B
Endo Inc.	1.64B
Nika Pharmaceuticals	1.02B
Veradigm	704.15M
Elite Pharmaceuticals	437.70M
Northwest Biotherapeutics	402.62M
Glass House Brands	384.26M
CytoDyn	264.36M

Market Cap Rankings